Navigation Links
UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
Date:6/15/2009

PITTSBURGH, Pennsylvania, and JERUSALEM, Israel, June 15 /PRNewswire/ -- The University of Pittsburgh Cancer Institute (UPCI) and the Gamida Cell - Teva Joint Venture announced today that the Institute has joined an elite group of cancer centers in Europe, the United States and Israel that are now enrolling patients to participate in the ExCell research study.

The phase III study is assessing the safety and efficacy of StemEx(R), an investigational product derived from stem cells, as an alternative treatment to bone marrow transplants for hematological malignancies, including leukemia and lymphoma. StemEx is a graft of expanded stem/progenitor cells taken from a single unit of umbilical cord blood and then transplanted in combination with non-expanded cells from the same unit.

"I am extremely pleased UPCI has the opportunity to be a part of this study," said Mounzer Agha, M.D., clinical director of UPCI's Hematopoietic Stem Cell Transplant Program. "Using umbilical cord blood stem cells instead of a traditional bone marrow transplant opens tremendous treatment possibilities for patients with diseases like leukemia and lymphoma."

Bone marrow transplantation is a life-saving treatment for many types of leukemia and lymphoma. However, more than half the number of patients in need of a transplant can't find matching bone marrow donors. Cord blood could be an alternative of choice.

Previous research has shown that umbilical cord blood stem cells offer a viable therapeutic option for leukemia and lymphoma patients without the necessity of a matched donor. Umbilical cord blood has two important advantages - it is a readily available source for stem cells and it has a lower matching requirement for patients. With StemEx(R), the cord blood unit is enriched with stem cells, which are critical for a successful transplantation.

"We are pleased to work with the able
'/>"/>

SOURCE Gamida Cell LTD
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
2. BARC Central Laboratory Joins Alzheimers Association Research Roundtable
3. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
4. Photos: Sentara Joins 4 U.S. Hospitals in International TARGIT Breast Cancer Trial
5. Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels
6. Vincent W. Renz Joins NewCardio as President
7. Judith Quinlan Joins Cytel as Vice President, Adaptive Trials
8. Dr. Peter Nash, Ph.D. Joins Mach One Corporation as Chief Scientist
9. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...N, France, Nov. 19 In response to ...ngerous and illegal medicines, Operation Pangea II...POL and the World Health Organization,s Internatio... (IMPACT) to highlight the dangers of buying medic... resulted in a series of arrests and the seizure o...
(Date:11/19/2009)...BOTT PARK, Ill., Nov. 19 ... ABT ) as one of its Most Admired Corporate Dealma...honored Abbott as its Most Admired Dealmaker in ph...of acquisitions and divestitures since January 200... its business portfolio with a focus on high-growt...
(Date:11/19/2009)...PORT NEWS, Va., Nov. 19 Breast-Spe.../MBI) has been recognized and endorsed by two high...east cancer: The Society of Breast Imaging (SBI) a...s published articles supporting the further applic...the early detection of breast cancer. ,, "These...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3Central Blood Bank Offers Twilight Fans a way to be Among First to see the Highly Anticipated Sequel New Moon 60202 1Central Blood Bank Offers Twilight Fans a way to be Among First to see the Highly Anticipated Sequel New Moon 60202 2Central Blood Bank Offers Twilight Fans a way to be Among First to see the Highly Anticipated Sequel New Moon 60202 3Beverly Hills Doctor 28drfeiz com 29 Performs the Worlds Most Lap Band Surgeries 60199 1Beverly Hills Doctor 28drfeiz com 29 Performs the Worlds Most Lap Band Surgeries 60199 2Federal agencies to discuss best ways to prioritize evaluate scientific research 10549 1
...onth: Time to Pay Attention to this,Overlooked Dis...re/ -- During,National Sexually Transmitted Diseas...cal is urging increased awareness of, and,testing ...ost,common curable STD in the United States. Aware...t that trich affects an estimated 7.4,million men ...
...S WIRE)--Mar 30, 2007 - NEOPHARM, Inc.,(Nasdaq: NE...l,trial in second-line metastatic colorectal cance..., the active metabolite of irinotecan,(Camptosar(R...he,completion of treatment of the first 21 patient...d not achieve the primary tumor,response endpoint....
Other Medicine Technology:Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million,Annually 2Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million,Annually 3NeoPharm Provides Update on LE-SN38 Program 2
(Date:11/21/2009)...Nov. 21 Tonight, in a p...Senator Reid,s version of the government takeover ...ems included in this bill; like the public option,...nt funding for elective abortion, which is the mos...the bill provides subsidies for private plans that...
(Date:11/21/2009)...ll provides for an unprecedented expansion of fede...f it is not for preserving and protecting human li...d." Charmaine Yoest ,, WASHINGTON, Nov. 21 /...e Action President and CEO Dr. Charmaine Yoest res...g the following statement: ,, "This was a pro-...
(Date:11/21/2009)... Nov. 21 A regional ini...rciasis (river blindness) in the Americas has subs... recent years, as evidenced by a 31% decrease in t...istration in six endemic countries. Results were ...merican Society of Tropical Medicine and Hygiene (...
(Date:11/21/2009)...vember 21, 2009 Test Tes...t Test Test Test Test Test Test Test,Test Test Tes...t Test Test,Test Test Test Test Test Test Test Tes...st More test More test More test More test More te...st More test More test More,test More test , , ...
(Date:11/21/2009)... Innovative medical apparel company launches men,... San Clemente, Calif. (PRWEB) Novemb...h medical apparel, today announced the launch of i... 2009, a leading international trade fair for the ...lita inaugurates its men,s collection with three v...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3
...en as people struggle to cope with economic uncert...,s still possible to live a joyful, vital "best" l...y years, Harvard trained psychiatrist Dr. Richar...how to find the "best" in our living, the despair ...
... John K. Davis, II has been named Senior Vice Pre...an Board of Internal Medicine (ABIM), effective Ap...will work closely with senior management and the B...gy initiatives that support ABIM,s mission to ensu...
...e Mashour and David Glick highlight the serious is...view published by F1000 Medicine Reports. , Consc...y distressing condition leading to post-operative ...esthesia and Pain Management, writes that intra-op...
... 2 Helen of Troy Limited (Nasdaq: HELE ), desig...e personal care and household consumer products, t...reviously reported agreement to acquire the global... a trusted reputation with stylists and consumers ...
... 2 Spring is in the air, and along with it, tree,...y sufferer,s immune system a curve ball. But the A...Balanced Living magazine uncovers five other su... allergens as foreign bodies and launches an infla...
... InVitria,s Recombinant Albumin-DX eliminates s...d enhances diagnostic performance by improving spe... CO (PRWEB) April 2, 2009 -- Addressing significan... albumin products. InVitria,s Recombinant Albumin-...
Other Medicine News:Health News:Psychiatrist Dr. Richard Esser: How to Find the Best of Life in the Worst of Times 2Health News:John K. Davis, II to Join the American Board of Internal Medicine as Chief Information Officer 2Health News:Helen of Troy Limited Announces Closing of Global Infusium Brand Acquisition From Procter & Gamble 2Health News:Helen of Troy Limited Announces Closing of Global Infusium Brand Acquisition From Procter & Gamble 3Health News:Helen of Troy Limited Announces Closing of Global Infusium Brand Acquisition From Procter & Gamble 4Health News:Surprising Allergy Triggers May Be Making Your Spring Sniffles Worse 2Health News:InVitria Announces Launch of Recombinant Albumin for Diagnostics 2
Williams Eye Speculum - 14 mm
Castroviejo Speculum - 15 mm
Snare Wire
Thorton Fixation Ring 13 mm
Medicine Products: